Hylands Assists Chunlizhengda Medical Instruments in the IPO Project to Return from H Shares to A Shares with Successful Registration Approval from the China Securities Regulatory Commission Recently

Recently, Beijing Chunlizhengda Medical Instruments Co., Ltd. (hereinafter referred to as "Chunlizhengda Medical Instruments") has issued its initial public offering of ordinary shares (A shares) in RMB and received approval from the China Securities Regulatory Commission (CSRC) for IPO registration on the Science and Technology Innovation Board (STAR) of the Shanghai Stock Exchange. And Hylands has provided special legal services in this process.

Established in February 1998, Chunlizhengda Medical Instruments specializes in the R&D, production and sales of implantable orthopedic medical devices, especially in artificial joint products such as knee and hip joints, and has made remarkable achievements. Chunlizhengda Medical Instruments was listed on the Main Board of the Hong Kong Stock Exchange on March 11, 2015, with the abbreviation of H-share: Chunlizhengda Medical Instruments, and the stock code: 01858.HK. Chunlizhengda Medical Instruments intends to raise RMB 2 billion for the initial IPO, which will be mainly used for the comprehensive construction project of orthopedic implants and supporting materials, the R&D center construction project, the marketing network construction project, etc., with the expectation of contributing further to alleviating the suffering of patients and improving their quality of life and health.As the special legal advisor of the Project, a team of lawyers consisting of Partner Tiehu MU, Practicing Lawyer Yuan ZHAO and Field Managing Lawyer Lingling ZHENG provided overall process legal services for the IPO Project of Chunlizhengda Medical Instruments back to A shares from H shares. 

With such efforts, the lawyer teams of Hylands have accumulated extensive and concrete practical experience in medical devices and even pharmaceutical manufacturing, the compatibility and application of the laws at the two sites as well as the compliance of customs and foreign exchanges involved in business operation.